Plasmax™: Chest - Lung
Some of the information contained on this webpage pertains to products, indications for use of products and/or therapies that are only available outside the United States and have not been approved or cleared for marketing by the United States Food & Drug Administration.
Kjaergard HK, Weis-Fogh US, Sorensen H, Thiis J, Rygg I. Autologous fibrin glue – preparation and clinical use in thoracic surgery. Eur J Cardiothorac Surg 1992;6(1):52-4.
Summary: Autologous fibrin glue was applied during lung resection operations to reduce pulmonary air leak in twenty patients. Hemostasis was achieved and air leak was reduced with the use of fibrin glue, with no adverse reactions.
Quotation: “In summary, we report a new technique for preparing autologous fibrin glue with a high concentration of fibrinogen making it a safe and effective sealant of pulmonary air leak and hemostatic agent in thoracic surgery.”
Nicholas JM, Dulchavsky SA. Successful use of autologous fibrin gel in traumatic bronchopleural fistula: case report. J Trauma 1992;32(1):87-8.
Summary: Autologous fibrin sealant produced from platelet-poor plasma was introduced through a chest tube to treat a traumatic bronchopleural fistula. The pneumothorax was resolved within a few hours.
Quotation: “Fibrin gel pleurodesis is rapid, safe, and inexpensive and may decrease morbidity in prolonged traumatic bronchopleural fistula.”